Table 2.
Clinical events in patients with MMD treated with RIC or sham RIC
| Variables | RIC group (n = 23) | Sham RIC group (n = 23) |
|---|---|---|
| 1-y follow-up, n (%) | ||
| Incidence of the MACEs | 0 (0.00) | 3 (13.04) |
| Incidence of the IS | 0 (0.00) | 0 (0.00) |
| Incidence of the TIAs | 0 (0.00) | 2 (8.70) |
| Incidence of the revascularization surgery | 0 (0.00) | 1 (4.35) |
| 3-y follow-up, n (%) | ||
| Incidence of the MACEs | 1 (4.35) | 7 (30.43) |
| Incidence of the IS | 0 (0.00) | 2 (8.70) |
| Incidence of the TIAs | 1 (4.35) | 3 (13.04) |
| Incidence of the revascularization surgery | 0 (0.00) | 2 (8.70) |
MMD moyamoya disease, RIC remote ischemic conditioning, MACEs major adverse cerebrovascular events, IS ischemic stroke, TIAs transient ischemic attacks